NO20024821L - Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar - Google Patents
Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkarInfo
- Publication number
- NO20024821L NO20024821L NO20024821A NO20024821A NO20024821L NO 20024821 L NO20024821 L NO 20024821L NO 20024821 A NO20024821 A NO 20024821A NO 20024821 A NO20024821 A NO 20024821A NO 20024821 L NO20024821 L NO 20024821L
- Authority
- NO
- Norway
- Prior art keywords
- blood vessels
- diseases caused
- medicines
- stenotic lesions
- hydrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000104344 | 2000-04-06 | ||
| PCT/JP2001/002946 WO2001076587A1 (fr) | 2000-04-06 | 2001-04-05 | Remedes aux maladies associees aux lesions stenosees de vaisseaux sanguins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024821D0 NO20024821D0 (no) | 2002-10-04 |
| NO20024821L true NO20024821L (no) | 2002-12-06 |
Family
ID=18617901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024821A NO20024821L (no) | 2000-04-06 | 2002-10-04 | Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040068015A1 (pt) |
| EP (1) | EP1275385A1 (pt) |
| JP (1) | JPWO2001076587A1 (pt) |
| KR (1) | KR20020087124A (pt) |
| CN (1) | CN1434709A (pt) |
| AU (1) | AU4683601A (pt) |
| BR (1) | BR0109889A (pt) |
| CA (1) | CA2404775A1 (pt) |
| HU (1) | HUP0300368A3 (pt) |
| MX (1) | MXPA02009839A (pt) |
| NO (1) | NO20024821L (pt) |
| RU (1) | RU2002126568A (pt) |
| TW (1) | TW575421B (pt) |
| WO (1) | WO2001076587A1 (pt) |
| ZA (1) | ZA200207974B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102639146A (zh) * | 2009-05-27 | 2012-08-15 | 耶达研究及发展有限公司 | 蛋白酶体抑制剂及其用途 |
| MX2020007866A (es) * | 2018-02-01 | 2020-12-03 | Wellstat Therapeutics Corp | Composiciones y dispositivos para el suministro sistemico de uridina. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843089A (en) * | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
| US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
| IL125378A0 (en) * | 1996-01-23 | 1999-03-12 | Shionogi & Co | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| EP1024134A4 (en) * | 1997-10-09 | 2003-05-14 | Ono Pharmaceutical Co | DERIVATIVES OF AMINOBUTANIC ACID |
-
2001
- 2001-04-05 US US10/240,860 patent/US20040068015A1/en not_active Abandoned
- 2001-04-05 RU RU2002126568/15A patent/RU2002126568A/ru not_active Application Discontinuation
- 2001-04-05 JP JP2001574105A patent/JPWO2001076587A1/ja active Pending
- 2001-04-05 KR KR1020027013277A patent/KR20020087124A/ko not_active Application Discontinuation
- 2001-04-05 EP EP01919785A patent/EP1275385A1/en not_active Withdrawn
- 2001-04-05 MX MXPA02009839A patent/MXPA02009839A/es unknown
- 2001-04-05 CN CN01810822A patent/CN1434709A/zh active Pending
- 2001-04-05 BR BR0109889-6A patent/BR0109889A/pt not_active Application Discontinuation
- 2001-04-05 AU AU46836/01A patent/AU4683601A/en not_active Abandoned
- 2001-04-05 WO PCT/JP2001/002946 patent/WO2001076587A1/ja not_active Application Discontinuation
- 2001-04-05 HU HU0300368A patent/HUP0300368A3/hu unknown
- 2001-04-05 CA CA002404775A patent/CA2404775A1/en not_active Abandoned
- 2001-04-06 TW TW90108250A patent/TW575421B/zh active
-
2002
- 2002-10-03 ZA ZA200207974A patent/ZA200207974B/en unknown
- 2002-10-04 NO NO20024821A patent/NO20024821L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002126568A (ru) | 2004-03-20 |
| JPWO2001076587A1 (ja) | 2004-01-08 |
| MXPA02009839A (es) | 2003-09-22 |
| ZA200207974B (en) | 2004-02-10 |
| CA2404775A1 (en) | 2002-10-02 |
| WO2001076587A1 (fr) | 2001-10-18 |
| KR20020087124A (ko) | 2002-11-21 |
| EP1275385A1 (en) | 2003-01-15 |
| TW575421B (en) | 2004-02-11 |
| BR0109889A (pt) | 2003-06-03 |
| NO20024821D0 (no) | 2002-10-04 |
| CN1434709A (zh) | 2003-08-06 |
| HUP0300368A2 (hu) | 2003-07-28 |
| HUP0300368A3 (en) | 2004-07-28 |
| US20040068015A1 (en) | 2004-04-08 |
| AU4683601A (en) | 2001-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200614983A (en) | 5-substituted-2-phenylamino benzamides as MEK inhibitors | |
| FI950309A (fi) | Proliiniamidijohdannaisia | |
| LU90956I2 (fr) | Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique | |
| NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
| CA2223403A1 (en) | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds | |
| CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| IT1305306B1 (it) | Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia. | |
| BG104797A (en) | Use of dexmedetomi dine for sedative effect in patients in an intensive care unit | |
| HUP9801924A2 (hu) | Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény | |
| DE60220055D1 (de) | 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| NO20024821L (no) | Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar | |
| RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
| SE0201837D0 (sv) | Chemical compounds | |
| SE9900190D0 (sv) | New compounds | |
| ES2123808T3 (es) | Derivado de acilfenilglicina y agente profilactico y curativo para enfermedades causadas por una actividad acrecentada de colagenasa, que contiene dicho compuesto como ingrediente activo. | |
| NO20043286L (no) | Piperidinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| ATE352317T1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
| ATE408413T1 (de) | Pralmorelin-haltige nasentropfen-präparate | |
| EP0950409A4 (en) | INHIBITORS OF SUBEPITHELIAL TURBIDITY | |
| DE60233578D1 (de) | Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung | |
| WO2003018564A1 (fr) | Inhibiteur d'acat selectif de la paroi vasculaire | |
| DE60106246D1 (de) | Malto-oligosaccharide und deren verwendung | |
| EP1228761A3 (en) | Liquid pharmaceutical composition for treating bone diseases | |
| BR0007894A (pt) | Emprego de moxonidina para tratamento apósinfarto cardìaco |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |